Stefani Wolff

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Ryan Murr, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stefani Wolff:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. EVP and COO Restricted Stock Units 10,582 $84,552 $7.99 30 Apr 2023 Direct
Nurix Therapeutics, Inc. EVP and COO Common Stock 6,113 $61,149 $10.00 01 May 2023 Direct
Rain Oncology Inc. Director Stock Option (Right to Buy) 0 26 Jan 2024 Direct

Insider Reports Filed by Stefani Wolff

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000199937124000976-wolff-stefani-2024-01-26 Rain Oncology Inc. 26 Jan 2024 3 $0 4 Director 26 Jan 2024, 16:50
/report/000110465923090700-wolff-stefani-2023-08-09 Rain Oncology Inc. 09 Aug 2023 1 $0 4 Director 11 Aug 2023, 21:09
NRIX Nurix Therapeutics, Inc. 30 Apr 2023 3 -$3,378 4 EVP and COO 02 May 2023, 16:33
NRIX Nurix Therapeutics, Inc. 14 Feb 2023 2 $0 4 EVP and COO 15 Feb 2023, 15:14
NRIX Nurix Therapeutics, Inc. 30 Jan 2023 3 -$4,995 4 EVP and COO 01 Feb 2023, 15:18
NRIX Nurix Therapeutics, Inc. 30 Oct 2022 3 -$4,508 4 EVP and COO 01 Nov 2022, 19:32
NRIX Nurix Therapeutics, Inc. 09 Aug 2022 1 $0 4 EVP and COO 10 Aug 2022, 16:18
NRIX Nurix Therapeutics, Inc. 30 Jul 2022 3 -$5,579 4 EVP and COO 02 Aug 2022, 17:48
/report/000089924322029316-wolff-stefani-2022-06-01 Rain Therapeutics Inc. 01 Jun 2022 1 $0 4 Director 19 Aug 2022, 17:38
NRIX Nurix Therapeutics, Inc. 30 Apr 2022 3 -$3,878 4 EVP and COO 03 May 2022, 19:04
NRIX Nurix Therapeutics, Inc. 19 Jan 2022 2 $0 4 EVP and COO 21 Jan 2022, 15:17
NRIX Nurix Therapeutics, Inc. 16 Aug 2021 0 $0 3 EVP and COO 17 Aug 2021, 17:19
/report/000089924321019787-wolff-stefani-2021-05-14 Rain Therapeutics Inc. 14 May 2021 1 $0 4 Director 18 May 2021, 17:44